Cargando…

A(2)DS(2) Score Combined With Clinical and Neuroimaging Factors Better Predicts Stroke-Associated Pneumonia in Hyperacute Cerebral Infarction

OBJECTIVE: To investigate the predictors of stroke-associated pneumonia (SAP) and poor functional outcome in patients with hyperacute cerebral infarction (HCI) by combining clinical factors, laboratory tests and neuroimaging features. METHODS: We included 205 patients with HCI from November 2018 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yaoyao, Xia, Tianyi, Tan, Zhouli, Xia, Huwei, He, Shenping, Sun, Han, Wang, Xifan, Song, Haolan, Chen, Weijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855060/
https://www.ncbi.nlm.nih.gov/pubmed/35185764
http://dx.doi.org/10.3389/fneur.2022.800614
_version_ 1784653573576982528
author Yu, Yaoyao
Xia, Tianyi
Tan, Zhouli
Xia, Huwei
He, Shenping
Sun, Han
Wang, Xifan
Song, Haolan
Chen, Weijian
author_facet Yu, Yaoyao
Xia, Tianyi
Tan, Zhouli
Xia, Huwei
He, Shenping
Sun, Han
Wang, Xifan
Song, Haolan
Chen, Weijian
author_sort Yu, Yaoyao
collection PubMed
description OBJECTIVE: To investigate the predictors of stroke-associated pneumonia (SAP) and poor functional outcome in patients with hyperacute cerebral infarction (HCI) by combining clinical factors, laboratory tests and neuroimaging features. METHODS: We included 205 patients with HCI from November 2018 to December 2019. The diagnostic criterion for SAP was occurrence within 7 days of the onset of stroke. Poor outcome was defined as a functional outcome based on a 3-months MRS score >3. The relationship of demographic, laboratory and neuroimaging variables with SAP and poor outcome was investigated using univariate and multivariate analyses. RESULTS: Fifty seven (27.8%) patients were diagnosed with SAP and 40 (19.5%) developed poor outcomes. A(2)DS(2) score (OR = 1.284; 95% CI: 1.048–1.574; P = 0.016), previous stroke (OR = 2.630; 95% CI: 1.122–6.163; P = 0.026), consciousness (OR = 2.945; 95% CI: 1.514–5.729; P < 0.001), brain atrophy (OR = 1.427; 95% CI: 1.040–1.959; P = 0.028), and core infarct volume (OR = 1.715; 95% CI: 1.163–2.528; P = 0.006) were independently associated with the occurrence of SAP. Therefore, we combined these variables into a new SAP prediction model with the C-statistic of 0.84 (95% CI: 0.78–0.90). Fasting plasma glucose (OR = 1.404; 95% CI: 1.202–1.640; P < 0.001), NIHSS score (OR = 1.088; 95% CI: 1.010–1.172; P = 0.026), previous stroke (OR = 4.333; 95% CI: 1.645–11.418; P = 0.003), SAP (OR = 3.420; 95% CI: 1.332–8.787; P = 0.011), basal ganglia-dilated perivascular spaces (BG-dPVS) (OR = 2.124; 95% CI: 1.313–3.436; P = 0.002), and core infarct volume (OR = 1.680; 95% CI: 1.166–2.420; P = 0.005) were independently associated with poor outcome. The C-statistic of the outcome model was 0.87 (95% CI: 0.81–0.94). Furthermore, the SAP model significantly improved discrimination and net benefit more than the A(2)DS(2) scale, with a C-statistic of 0.76 (95% CI: 0.69–0.83). CONCLUSIONS: After the addition of neuroimaging features, the models exhibit good differentiation and calibration for the prediction of the occurrence of SAP and the development of poor outcomes in HCI patients. The SAP model could better predict the SAP, representing a helpful and valid tool to obtain a net benefit compared with the A(2)DS(2) scale.
format Online
Article
Text
id pubmed-8855060
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88550602022-02-19 A(2)DS(2) Score Combined With Clinical and Neuroimaging Factors Better Predicts Stroke-Associated Pneumonia in Hyperacute Cerebral Infarction Yu, Yaoyao Xia, Tianyi Tan, Zhouli Xia, Huwei He, Shenping Sun, Han Wang, Xifan Song, Haolan Chen, Weijian Front Neurol Neurology OBJECTIVE: To investigate the predictors of stroke-associated pneumonia (SAP) and poor functional outcome in patients with hyperacute cerebral infarction (HCI) by combining clinical factors, laboratory tests and neuroimaging features. METHODS: We included 205 patients with HCI from November 2018 to December 2019. The diagnostic criterion for SAP was occurrence within 7 days of the onset of stroke. Poor outcome was defined as a functional outcome based on a 3-months MRS score >3. The relationship of demographic, laboratory and neuroimaging variables with SAP and poor outcome was investigated using univariate and multivariate analyses. RESULTS: Fifty seven (27.8%) patients were diagnosed with SAP and 40 (19.5%) developed poor outcomes. A(2)DS(2) score (OR = 1.284; 95% CI: 1.048–1.574; P = 0.016), previous stroke (OR = 2.630; 95% CI: 1.122–6.163; P = 0.026), consciousness (OR = 2.945; 95% CI: 1.514–5.729; P < 0.001), brain atrophy (OR = 1.427; 95% CI: 1.040–1.959; P = 0.028), and core infarct volume (OR = 1.715; 95% CI: 1.163–2.528; P = 0.006) were independently associated with the occurrence of SAP. Therefore, we combined these variables into a new SAP prediction model with the C-statistic of 0.84 (95% CI: 0.78–0.90). Fasting plasma glucose (OR = 1.404; 95% CI: 1.202–1.640; P < 0.001), NIHSS score (OR = 1.088; 95% CI: 1.010–1.172; P = 0.026), previous stroke (OR = 4.333; 95% CI: 1.645–11.418; P = 0.003), SAP (OR = 3.420; 95% CI: 1.332–8.787; P = 0.011), basal ganglia-dilated perivascular spaces (BG-dPVS) (OR = 2.124; 95% CI: 1.313–3.436; P = 0.002), and core infarct volume (OR = 1.680; 95% CI: 1.166–2.420; P = 0.005) were independently associated with poor outcome. The C-statistic of the outcome model was 0.87 (95% CI: 0.81–0.94). Furthermore, the SAP model significantly improved discrimination and net benefit more than the A(2)DS(2) scale, with a C-statistic of 0.76 (95% CI: 0.69–0.83). CONCLUSIONS: After the addition of neuroimaging features, the models exhibit good differentiation and calibration for the prediction of the occurrence of SAP and the development of poor outcomes in HCI patients. The SAP model could better predict the SAP, representing a helpful and valid tool to obtain a net benefit compared with the A(2)DS(2) scale. Frontiers Media S.A. 2022-02-04 /pmc/articles/PMC8855060/ /pubmed/35185764 http://dx.doi.org/10.3389/fneur.2022.800614 Text en Copyright © 2022 Yu, Xia, Tan, Xia, He, Sun, Wang, Song and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Yu, Yaoyao
Xia, Tianyi
Tan, Zhouli
Xia, Huwei
He, Shenping
Sun, Han
Wang, Xifan
Song, Haolan
Chen, Weijian
A(2)DS(2) Score Combined With Clinical and Neuroimaging Factors Better Predicts Stroke-Associated Pneumonia in Hyperacute Cerebral Infarction
title A(2)DS(2) Score Combined With Clinical and Neuroimaging Factors Better Predicts Stroke-Associated Pneumonia in Hyperacute Cerebral Infarction
title_full A(2)DS(2) Score Combined With Clinical and Neuroimaging Factors Better Predicts Stroke-Associated Pneumonia in Hyperacute Cerebral Infarction
title_fullStr A(2)DS(2) Score Combined With Clinical and Neuroimaging Factors Better Predicts Stroke-Associated Pneumonia in Hyperacute Cerebral Infarction
title_full_unstemmed A(2)DS(2) Score Combined With Clinical and Neuroimaging Factors Better Predicts Stroke-Associated Pneumonia in Hyperacute Cerebral Infarction
title_short A(2)DS(2) Score Combined With Clinical and Neuroimaging Factors Better Predicts Stroke-Associated Pneumonia in Hyperacute Cerebral Infarction
title_sort a(2)ds(2) score combined with clinical and neuroimaging factors better predicts stroke-associated pneumonia in hyperacute cerebral infarction
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855060/
https://www.ncbi.nlm.nih.gov/pubmed/35185764
http://dx.doi.org/10.3389/fneur.2022.800614
work_keys_str_mv AT yuyaoyao a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction
AT xiatianyi a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction
AT tanzhouli a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction
AT xiahuwei a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction
AT heshenping a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction
AT sunhan a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction
AT wangxifan a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction
AT songhaolan a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction
AT chenweijian a2ds2scorecombinedwithclinicalandneuroimagingfactorsbetterpredictsstrokeassociatedpneumoniainhyperacutecerebralinfarction